Ryder System, Inc. (FRA:RYD)
Germany · Delayed Price · Currency is EUR | Market Cap | 8.57B +46.0% |
| Revenue (ttm) | 10.98B -0.1% |
| Net Income | 425.84M -1.6% |
| EPS | 10.45 +4.9% |
| Shares Out | n/a |
| PE Ratio | 20.14 |
| Forward PE | 16.79 |
| Dividend | 3.11 (1.41%) |
| Ex-Dividend Date | May 18, 2026 |
| Volume | n/a |
| Open | 220.00 |
| Previous Close | 212.00 |
| Day's Range | 216.00 - 220.00 |
| 52-Week Range | 125.00 - 220.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 23, 2026 |
About Ryder System
Ryder System, Inc. operates as a logistics and transportation company worldwide. It operates through three segments: Fleet Management Solutions (FMS), Supply Chain Solutions (SCS), and Dedicated Transportation Solutions (DTS). The FMS segment offers full-service leasing and leasing with flexible maintenance options; commercial vehicle rental; maintenance services; digital and technology support services; fuel services; and fuel planning and tax reporting, cards, and monitoring services, and centralized billing, as well as sells used vehicles th... [Read more]
Financial Performance
In 2025, Ryder System's revenue was $12.67 billion, an increase of 0.23% compared to the previous year's $12.64 billion. Earnings were $496.00 million, an increase of 2.06%.
Financial numbers in USD Financial StatementsNews
Ryder CEO John Diez to Address Wells Fargo 16th Industrials & Materials Conference
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder System, Inc. (NYSE: R) CEO John Diez to address the Wells Fargo 16th Industrials & Materials Conference. Who: Ryder System, Inc. CEO John Diez What: W...
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medica...
Core Critical Approved for Listing on OTCQB(R) Venture Market
VANCOUVER, BC / ACCESS Newswire / May 29, 2026 / Core Critical Metals Corp. ("CCMC" or the "Company") (TSXV:CCMC)(OTCQB:CCMCF) (WKN: A41G8G), a North American mineral acquisition and exploration compa...
Theralase(R) Releases Q1 2026 Financial Statements
Theralase(R) Provides an Update on its Phase II Bladder Cancer Clinical Study Toronto, Ontario--(Newsfile Corp. - May 29, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" ...
New phase III Translational Data Show DiviTum(R) TKa Captures Treatment-Specific Biological Response in Metastatic Breast Cancer
UPPSALA, SE / ACCESS Newswire / May 28, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, specializing in blood-based cancer monitoring, today announced new data published ...
Totec Resources Approved for Listing on OTCQB(R) Venture Market
VANCOUVER, BC / ACCESS Newswire / May 27, 2026 / Totec Resources Ltd. ("Totec" or the "Company") (TSXV:TOTC)(OTCQB:TTCRF)(FSE:U0Z0), a leading resource company focused on critical metals and supportin...
HigherVisibility Introduces Targeted Growth System(R) for Brands Competing in AI Search
The framework centers on site speed, server response, and technical reliability as AI retrieval becomes a filter for citation and discovery. Memphis, Tennessee--(Newsfile Corp. - May 27, 2026) - Leadi...
Ryder Earns VETS Indexes 3 Star Employer Award for 2026
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) has been recognized as a 3 Star Employer in the 2026 VETS Indexes Employer Awards, underscoring the company's long‑standing commitment to recruitin...
KottonSpa(TM) Debuts World's First Collection of SUPIMA(R) Muslin Baby Essentials.
New York, New York--(Newsfile Corp. - May 25, 2026) - KottonSpa™, a Texas-founded newborn brand that launched in March, introduced a collection of newborn essentials crafted entirely from 100% America...
BioInvent Reveals Solid Data with its TNFR2 Antibody BI-1808 and KEYTRUDA(R) (pembrolizumab) in Advanced Ovarian Cancer at ASCO
BioInvent International (STO:BINV) 24% confirmed ORR (including complete response) in heavily pretreated patients (n=25) with advanced ovarian cancer who received BI-1808 and KEYTRUDA - multiplying by...
Theralase(R) Closes C$4.8 Million Offering
Toronto, Ontario--(Newsfile Corp. - May 20, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the re...
Vera Quinn of Cydcor Named Entrepreneur Of the Year(R) 2026 Greater Los Angeles Finalist by EY US
EY US celebrates ambitious entrepreneurs shaping the future of business Los Angeles, California--(Newsfile Corp. - May 19, 2026) - Vera Quinn, CEO of Cydcor, has been named a finalist for the Entrepre...
GMG's THERMAL-XR(R) to be Applied Exclusively & Distributed to Global Oil and Gas/LNG Industry with Curran International
Brisbane, Queensland, Australia--(Newsfile Corp. - May 19, 2026) - Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce the signing of a global d...
Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM 2026 Conference
LUND, SE / ACCESS Newswire / May 18, 2026 / Spago Nanomedical AB (publ)(STO:SPAGO.ST)(FRA:7UX.F) today announces that case findings from its ongoing Phase I/IIa clinical study Tumorad-01 have been pre...
Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program
TORONTO, ON / ACCESS Newswire / May 13, 2026 / Retained executive search firm Caldwell (TSX:CWL)(OTCQX:CWLPF) today announced the relaunch of Canada's Top 40 Under 40® Award Program, renewing its comm...
Tenon(R) Medical Reports First Quarter 2026 Financial Results
~ First Quarter 2026 Revenue of $1.4 Million, an Increase of Approximately 90% Compared to Prior Year ~ ~ First Quarter Gross Profit of $0.9 Million, an Increase of Approximately 193% Compared to Prio...
Ryder System Transcript: Bank of America’s 33th Annual Industrials, Transportation and Airlines Key Leaders Conference
Operations are focused on North America with a balanced growth strategy, shifting toward asset-light and contractual businesses. Early signs of freight market recovery, strong used vehicle pricing, and technology investments—including AI and autonomous pilots—support improved margins and growth. Guidance was raised on better Q1 performance and market trends.
BioInvent's TNFR2 Antibody BI-1808 Shows Strong Activity and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026)
40% objective response rate ( ORR) as single agent in heavily pre - treated patients with advanced Cutaneous T-Cell Lymphoma (CTCL) Durable responses observed, including a complete response lasting ...
BioInvent to Present Clinical Data on FcγRIIB Antibody BI-1206 Triplet Combination Therapy with rituximab and Calquence(R) in Relapsed/Refractory NHL at EHA 2026
LUND, SE / ACCESS Newswire / May 12, 2026 / BioInvent International (STO:BINV) - BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a leader in the discovery of novel immune-modulatory ...
Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
~ Patent Extends Jurisdiction and Protection Through 2042 ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage phar...
Quarterly Report Q1 2026: Orviglance(R) Approaching Transformative Milestones
MALMÖ, SE / ACCESS Newswire / May 12, 2026 / Ascelia Pharma AB (publ) (STO:ACE) today published its Interim Report Q1 for 2026 (January - March), which is now available on the company's website: Finan...
Theralase(R) Announces $4 Million Brokered LIFE Offering
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Theralase® Technologies Inc. (TSXV: TLT...
Ryder CEO to Address Bank of America Securities Industrials, Transportation, and Airlines Key Leaders Conference
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder System, Inc. (NYSE: R) Chief Executive Officer John Diez will present a company update at the 2026 Bank of America Securities Industrials, Transportati...
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the res...
Gelum Shares Approved for Trading on the OTCQB(R) Venture Market
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Gelum Resources Ltd. (CSE: GMR) (OTCQB: GMRCF) ("Gelum" or the "Company") reports that the Company's common shares have been re-approved a...